Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Vabysmo shows signs of recovery as Roche gears up for busy 2027
As the Vabysmo market stabilizes, Roche and investors are turning their attention to several potential blockbuster launches in the next few months.
Angus Liu
Oct 22, 2026 11:20am
AZ lands 5th Ultomiris indication in kidney disease IgAN
Oct 22, 2026 11:15am
Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue
Brought to you by
Bain & Company
Esteve pledges $80M to overhaul its CDMO operations in China
Oct 22, 2026 10:52am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Pfizer's cost savings drive touches jobs at US, Europe plants
Oct 22, 2026 9:32am
